Back
Mitek Systems 10K Form
Sell
31
MITK
Mitek Systems
Last Price:
$8.98
Seasonality Move:
7.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-10 | 10Q | MITK/Mitek Systems Quarterly |
2024-04-15 | 10Q | MITK/Mitek Systems Quarterly |
2023-10-26 | 10Q | MITK/Mitek Systems Quarterly |
2023-09-29 | 10Q | MITK/Mitek Systems Quarterly |
2023-09-06 | 10Q | MITK/Mitek Systems Quarterly |
2022-10-28 | 10Q | MITK/Mitek Systems Quarterly |
Receive MITK News And Ratings
See the #1 stock for the next 7 days that we like better than MITK
MITK Financial Statistics
Sales & Book Value
Annual Sales: | $172.1M |
---|---|
Cash Flow: | $230K |
Price / Cash Flow: | 10.51 |
Annual Sales: | $4.44 |
Price / Book: | 2.02 |
Profitability
EPS (TTM): | 0.09450 |
---|---|
Net Income (TTM): | $4.5M |
Gross Margin: | $147.7M |
Return on Equity: | 2.11% |
Return on Assets: | 1.09% |
Mitek Systems Earnings Forecast
Key Mitek Systems Financial Ratios
-
The Gross Profit Margin over the past 37 years for MITK is 85.82%.
-
The Selling, General & Administrative Expenses for MITK have been equal to 54.49% of Gross Profit Margin.
-
The Research & Development expenses have been 20.13% of Revenue.
-
The Interest Expense is 282.46% of Operating Income.
-
The Net Earning history of MITK is 1.90% of Total Revenues.
-
Per Share Earnings over the last 37 years have been positive in 21 years.
Mitek Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | MITK |
CUSIP: | 606710 |
Website: | miteksystems.com |
Debt
Debt-to-Equity Ratio: | 0.73 |
---|---|
Current Ratio: | 4.59 |
Quick Ratio: | 4.39 |
Price-to-Earnings
Trailing P/E Ratio: | 128.29 |
---|---|
Forward P/E Ratio: | 8.2 |
MITK Technical Analysis vs Fundamental Analysis
Sell
31
Mitek Systems (MITK)
is a Sell
Is Mitek Systems a Buy or a Sell?
-
Mitek Systems stock is rated a SellThe current Mitek Systems [MITK] share price is $8.98. The Score for MITK is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.